| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.3M | +30.8% |
| R&D Expense | $173.0M | +10.5% |
| SG&A Expense | $72.2M | +19.5% |
| Operating Income | -$209.9M | -10.5% |
| Pre-tax Income | -$173.8M | +3.0% |
| Income Tax | -$4.8M | -427.0% |
| Net Income | -$169.0M | +6.4% |
| EPS (Basic) | -$2.90 | +42.9% |
| EPS (Diluted) | -$2.90 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $879.5M | +67.1% |
| Accounts Receivable | $0 | — |
| Current Assets | $928.6M | +65.3% |
| Total Assets | $956.9M | +60.7% |
| Current Liabilities | $67.2M | -3.3% |
| Long-term Debt | $30.7M | +0.0% |
| Total Liabilities | $163.8M | -27.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$164.7M | -171.7% |
| Capital Expenditures | $1.2M | -57.8% |
| Investing Cash Flow | -$1.2M | +57.8% |
| Financing Cash Flow | $519.8M | +107.9% |
| Free Cash Flow | -$166.0M | -161.1% |
| +42.9% |
| Stockholders' Equity |
| $793.1M |
| +113.8% |